Ligand Pharmaceuticals | Passività Correnti





Passività Correnti Cambiamento Data
Agenus USD 287.13M 52.57M 2025-09
Amgen USD 25.49B 3.7B 2025-12
Anika Therapeutics USD 19.09M 3.01M 2025-09
Arrowhead Research USD 347.42M 151.94M 2025-12
Baxter International USD 2.97B 805M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Enviri Corporation USD 639.42M 13.36M 2025-09
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Glaxosmithkline GBP 28.68B 8.3B 2025-09
Heron Therapeutics USD 89.71M 168.89M 2025-09
Insmed USD 468.87M 51.66M 2025-12
Intrexon USD 23.02M 38K 2024-06
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
MacroGenics USD 44.47M 5.47M 2025-09
Merck USD 28.63B 2.59B 2025-09
Pacira USD 120.59M 13.51M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Veracyte USD 59.94M 12.22M 2025-12


Ligand Pharmaceuticals Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.